Safe prescribing of opioids for persistent non-cancer pain

Australian Prescriber

Volumn 35, Issue 1, 2012, Pages 20-24

  McDonough, Michael ^a  

^a WESTERN HOSPITAL   (Australia)

Author keywords

Adverse effects; Opiates; Substance use disorder

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; ADDICTION; ARTICLE; CENTRAL SLEEP APNEA SYNDROME; COGNITIVE DEFECT; CONSTIPATION; COORDINATION DISORDER; DRUG EFFICACY; DRUG LEGISLATION; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDEMA; EVIDENCE BASED MEDICINE; FLUID RETENTION; GALACTORRHEA; GASTROESOPHAGEAL REFLUX; HEMORRHOID; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; INTESTINAL DYSMOTILITY; INTOXICATION; MOOD DISORDER; NARCOTIC DEPENDENCE; NAUSEA; OCCUPATIONAL DISEASE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAIN; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT MONITORING; PATIENT PREFERENCE; PRESCRIPTION; PRURITUS; QT PROLONGATION; RESPIRATION DEPRESSION; SCREENING TEST; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; TREATMENT WITHDRAWAL; VOMITING;

EID: 84858115880     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2012.008     Document Type: Article

References (18)

1. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009;39:676-81.
2. Rintoul AC, Dobbin MD, Drummer OH, Ozanne-Smith J. Increasing deaths involving oxycodone, Victoria, Australia, 2000-2009. Inj Prev 2011;17:254-9.
3. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-21.
4. National Medicines Policy. Quality Use of Medicines. Department of Health and Ageing. 1999. www.health.gov.au/internet/main/publishing.nsf/Content/nmpquality.htm [cited 2012 Jan 6]
5. Wodak A, Cohen ML. The judicious use of opioids in managing chronic noncancer pain. Med Today 2010;11:10-8.
6. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a metaanalysis of effectiveness and side effects. CMAJ 2006;174:1589-94.
7. International Association for the Study of Pain [IASP]. Definition of pain. www.iasp-pain.org/AM/Template.cfm?Section=Pain_Defi.isplay.cfm&ContentID=1728 [cited 2012 Jan 6]
8. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
9. Prescription Opioid Policy: Improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use. Sydney 2009. www.racp.edu.au/index.cfm?objectid=D7FAA946-ACEE-2637-428D447EE5E581C3 [cited 2012 Jan 6]
10. Molloy A. Does pethidine still have a place in therapy? Aust Prescr 2002;25:12-3.
11. National Prescribing Service. My Pain Management Plan. 2010. www.nps.org.au/__data/assets/pdf_file/0005/88340/My_pain_plan.pdf [cited 2012 Jan 6]
12. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133-7.
13. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med 2009;10:537-48.
14. Ellis J, Mullan J. Prescription medication borrowing and sharing: risk factors and management. Aust Fam Physician 2009;38:816-9.
15. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80.
16. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171:686-91.
17. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170:1968-78.
18. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain 2010;150:332-9.